176 related articles for article (PubMed ID: 19356733)
1. Comparison of agmatine with moxonidine and rilmenidine in morphine dependence in vitro: role of imidazoline I(1) receptors.
Li F; Wu N; Su RB; Liu Y; Lu XQ; Li J
Eur J Pharmacol; 2009 Jun; 612(1-3):1-8. PubMed ID: 19356733
[TBL] [Abstract][Full Text] [Related]
2. IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence.
Wu N; Su RB; Xu B; Lu XQ; Liu Y; Zheng JQ; Piletz JE; Li J; Qin BY
Biochem Pharmacol; 2005 Oct; 70(7):1079-87. PubMed ID: 16112088
[TBL] [Abstract][Full Text] [Related]
3. Modulation of agmatine on calcium signal in morphine-dependent CHO cells by activation of IRAS, a candidate for imidazoline I1 receptor.
Wu N; Su RB; Liu Y; Lu XQ; Zheng JQ; Cong B; Li J
Eur J Pharmacol; 2006 Oct; 548(1-3):21-8. PubMed ID: 16962578
[TBL] [Abstract][Full Text] [Related]
4. Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence.
Li F; Wu N; Su R; Chen Y; Lu X; Liu Y; Li J
Addict Biol; 2012 Mar; 17(2):392-408. PubMed ID: 21967557
[TBL] [Abstract][Full Text] [Related]
5. Effect of agmatine on DAMGO-induced mu-opioid receptor down-regulation and internalization via activation of IRAS, a candidate for imidazoline I(1) receptor.
Gao Y; Li F; Wu N; Su RB; Liu Y; Lu XQ; Liu Y; Li J
Eur J Pharmacol; 2008 Dec; 599(1-3):18-23. PubMed ID: 18845140
[TBL] [Abstract][Full Text] [Related]
6. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
Szabo B; Urban R
Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
[TBL] [Abstract][Full Text] [Related]
7. Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein.
Li F; Wu N; Su RB; Zheng JQ; Xu B; Lu XQ; Cong B; Li J
J Cell Biochem; 2006 Aug; 98(6):1615-28. PubMed ID: 16598778
[TBL] [Abstract][Full Text] [Related]
8. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
Prichard BN; Graham BR
Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
[TBL] [Abstract][Full Text] [Related]
9. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine.
Chan CK; Head GA
J Hypertens; 1996 Jul; 14(7):855-64. PubMed ID: 8818924
[TBL] [Abstract][Full Text] [Related]
10. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
[TBL] [Abstract][Full Text] [Related]
11. Testing conception of engagement of imidazoline receptors in imidazoline drugs effects on isolated rat heart atria.
Radwanska A; Dlugokecka J; Wasilewski R; Kaliszan R
J Physiol Pharmacol; 2009 Mar; 60(1):131-42. PubMed ID: 19439815
[TBL] [Abstract][Full Text] [Related]
12. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
van Zwieten PA
J Hypertens; 1997 Feb; 15(2):117-25. PubMed ID: 9469786
[TBL] [Abstract][Full Text] [Related]
13. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
Chan CK; Sannajust F; Head GA
J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
[TBL] [Abstract][Full Text] [Related]
14. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
[TBL] [Abstract][Full Text] [Related]
15. Imidazoline receptor agonist drugs: a new approach to the treatment of systemic hypertension.
Yu A; Frishman WH
J Clin Pharmacol; 1996 Feb; 36(2):98-111. PubMed ID: 8852385
[TBL] [Abstract][Full Text] [Related]
16. Moxonidine and rilmenidine injected into the medial septal area reduces the salivation induced by pilocarpine.
Saad WA; de Arruda Camargo LA; Simões S; Saad WA; Guarda RS; Guarda IF
Auton Neurosci; 2004 May; 112(1-2):31-6. PubMed ID: 15233928
[TBL] [Abstract][Full Text] [Related]
17. Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.
Li P; Penner SB; Smyth DD
Br J Pharmacol; 1994 May; 112(1):200-6. PubMed ID: 8032642
[TBL] [Abstract][Full Text] [Related]
18. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
[TBL] [Abstract][Full Text] [Related]
19. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
Taksande BG; Kotagale NR; Patel MR; Shelkar GP; Ugale RR; Chopde CT
Eur J Pharmacol; 2010 Jul; 637(1-3):89-101. PubMed ID: 20394743
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
